Associated Papers
The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.
Lucas LM et al.
Pharmacological Reviews, 2022
Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib.
Bessette DC et al.
Plos One, 2015
25969993 (PubMed )
Supplement: pone.0125232.s010.xlsx › Table_S4
Select a paper to view details